Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950103-18-011246
Filing Date
2018-08-30
Accepted
2018-09-28 10:44:22
Documents
19

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1730048
2 filename2.htm EX-3.3 144150
3 filename3.htm EX-3.4 163677
4 filename4.htm EX-10.1 380918
5 filename5.htm EX-10.3 198037
6 filename6.htm EX-10.10 93984
7 filename7.htm EX-10.15 55456
8 GRAPHIC image_013.jpg GRAPHIC 3524
9 GRAPHIC drs_p3.jpg GRAPHIC 81977
10 GRAPHIC drs_p8.jpg GRAPHIC 151364
11 GRAPHIC drs_p66.jpg GRAPHIC 22194
12 GRAPHIC drs_p67.jpg GRAPHIC 172329
13 GRAPHIC drs_p100.jpg GRAPHIC 81376
14 GRAPHIC drs_p106.jpg GRAPHIC 56587
15 GRAPHIC drs_p108a.jpg GRAPHIC 37105
16 GRAPHIC drs_p108b.jpg GRAPHIC 37850
17 GRAPHIC drs_p109.jpg GRAPHIC 49076
18 GRAPHIC drs_p110.jpg GRAPHIC 51883
19 GRAPHIC drs_p114.jpg GRAPHIC 30673
  Complete submission text file 0000950103-18-011246.txt   3837245
Mailing Address 5420 LBJ FREEWAY, SUITE 410 DALLAS TX 75240
Business Address 5420 LBJ FREEWAY, SUITE 410 DALLAS TX 75240 214-593-0500
Arog Pharmaceuticals, Inc. (Filer) CIK: 0001753850 (see all company filings)

EIN.: 901074136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-02285 | Film No.: 181092836
SIC: 2834 Pharmaceutical Preparations